• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国普通公众对前列腺特异性抗原(PSA)知晓率的调查及影响因素分析。

Investigation of awareness rate of prostate-specific antigen (PSA) among the general public in China and analysis of influencing factors.

机构信息

School of Clinical Medicine, Fujian Medical University, Fuzhou, China.

Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.

出版信息

Front Public Health. 2023 May 4;11:1080800. doi: 10.3389/fpubh.2023.1080800. eCollection 2023.

DOI:10.3389/fpubh.2023.1080800
PMID:37213638
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10192882/
Abstract

OBJECTIVE

This study aimed to evaluate the awareness rate of prostate-specific antigen (PSA) among the general public in China and provide data about prostate cancer (PCa) for related scientific research.

METHODS

A cross-sectional survey of PSA awareness was conducted in multiple regional populations using an online questionnaire. The questionnaire included basic information, knowledge about PCa, the awareness rate and application of PSA, and future expectations toward applying PSA screening in clinical practice. The study applied the methods of Pearson chi-square analysis and Logistic regression analysis.

RESULTS

A total of 493 valid questionnaires were included. Two hundred and nineteen respondents (44.4%) were males, and 274 (55.6%) were females. Of all respondents, 212 (43.0%) were under 20 years old, 147 (29.8%) were 20-30 years old, 74 (15.0%) were 30-40 years old, and 60 (12.2%) were over 40 years old. There are 310 people (62.9%) with medical educational background and 183 (37.1%) without. One hundred eighty-seven (37.9%) of the respondents were aware of PSA, and 306 (62.1%) were unaware of PSA. Statistically significant differences were obtained between the two groups regarding different ages, educational backgrounds, occupations, departments, and habits of knowing medical knowledge (all < 0.05). In addition, the differences between the group of aware of PSA (AP) and the group unaware of PSA (UAP) in terms of whether they had been exposed to PSA screening and whether they had exposure to PCa patients or related knowledge were also observed (all < 0.05). Age ≥30 years, medical educational background, understanding of medical knowledge, exposure to PCa patients or related knowledge, exposure to PSA screening, and status as a graduate student and above were independent factors for the occurrence of PSA awareness events (all < 0.05). In addition, age ≥ 30 years, medical educational background, and awareness of PSA were independent factors for future expectations toward PSA (all < 0.05).

CONCLUSIONS

We first analyzed the public awareness of PSA. Cognition degrees of PSA and PCa awareness vary among different populations in China. Therefore, we should designate corresponding widespread scientific educational programs for different populations to increase the awareness rate of PSA.

摘要

目的

本研究旨在评估中国普通公众对前列腺特异性抗原(PSA)的认知率,并为前列腺癌(PCa)相关科学研究提供数据。

方法

采用在线问卷对多个地区人群进行 PSA 认知横断面调查。问卷内容包括基本信息、PCa 相关知识、对 PSA 的认知率和应用情况,以及对 PSA 临床应用的未来期望。本研究采用 Pearson 卡方检验和 Logistic 回归分析方法。

结果

共纳入 493 份有效问卷。219 名受访者(44.4%)为男性,274 名(55.6%)为女性。所有受访者中,212 名(43.0%)年龄在 20 岁以下,147 名(29.8%)年龄在 20-30 岁,74 名(15.0%)年龄在 30-40 岁,60 名(12.2%)年龄在 40 岁以上。有 310 名(62.9%)人具有医学教育背景,183 名(37.1%)人没有医学教育背景。187 名(37.9%)受访者知晓 PSA,306 名(62.1%)受访者不知晓 PSA。两组在年龄、教育背景、职业、科室和了解医学知识习惯等方面存在统计学差异(均<0.05)。此外,在是否接受过 PSA 筛查以及是否接触过 PCa 患者或相关知识方面,知晓 PSA(AP)组和不知晓 PSA(UAP)组之间也存在差异(均<0.05)。年龄≥30 岁、医学教育背景、了解医学知识、接触 PCa 患者或相关知识、接触 PSA 筛查以及研究生及以上学历是发生 PSA 知晓事件的独立因素(均<0.05)。此外,年龄≥30 岁、医学教育背景和 PSA 知晓是对 PSA 未来期望的独立因素(均<0.05)。

结论

本研究首次分析了公众对 PSA 的认知情况。中国不同人群对 PSA 和 PCa 的认知程度存在差异。因此,我们应针对不同人群制定相应的广泛科学教育计划,以提高 PSA 的知晓率。

相似文献

1
Investigation of awareness rate of prostate-specific antigen (PSA) among the general public in China and analysis of influencing factors.中国普通公众对前列腺特异性抗原(PSA)知晓率的调查及影响因素分析。
Front Public Health. 2023 May 4;11:1080800. doi: 10.3389/fpubh.2023.1080800. eCollection 2023.
2
Evaluating the use of prostate-specific antigen as an instrument for early detection of prostate cancer beyond urologists: results of a representative cross-sectional questionnaire study of general practitioners and internal specialists.评估前列腺特异性抗原作为非泌尿外科医生早期检测前列腺癌工具的应用:全科医生和内科专家代表性横断面问卷调查研究结果
Urol Int. 2014;93(2):160-9. doi: 10.1159/000356367. Epub 2014 Mar 5.
3
Knowledge and practices regarding prostate cancer screening in Spanish men: The importance of personal and clinical characteristics (PROSHADE study).西班牙语男性前列腺癌筛查知识和实践:个人和临床特征的重要性(PROSHADE 研究)。
PLoS One. 2024 May 30;19(5):e0303203. doi: 10.1371/journal.pone.0303203. eCollection 2024.
4
Knowledge of prostate cancer screening among native African urban population in Nigeria.尼日利亚本土非洲城市人口对前列腺癌筛查的了解情况。
Nig Q J Hosp Med. 2010 Apr-Jun;20(2):94-6. doi: 10.4314/nqjhm.v20i2.58044.
5
Physician Consultations, Prostate Cancer Knowledge, and PSA Screening of African American Men in the Era of Shared Decision-Making.共同决策时代非裔美国男性的医生咨询、前列腺癌知识与前列腺特异性抗原筛查
Am J Mens Health. 2018 Jul;12(4):751-759. doi: 10.1177/1557988318763673. Epub 2018 Apr 16.
6
Low-Value Prostate-Specific Antigen Screening in Older Males.老年男性低价值前列腺特异性抗原筛查。
JAMA Netw Open. 2023 Apr 3;6(4):e237504. doi: 10.1001/jamanetworkopen.2023.7504.
7
Knowledge of prostate cancer screening among native African urban population in Nigeria.尼日利亚本土非洲城市人口对前列腺癌筛查的了解情况。
Nig Q J Hosp Med. 2009 Jul-Sep;19(3):145-7. doi: 10.4314/nqjhm.v19i3.54494.
8
Prostate cancer screening: Knowledge, attitudes and practices in a sample of men in Italy. A survey.前列腺癌筛查:意大利男性样本中的认知、态度与行为。一项调查。
PLoS One. 2017 Oct 12;12(10):e0186332. doi: 10.1371/journal.pone.0186332. eCollection 2017.
9
Demographics and health-related factors of men receiving prostate-specific antigen screening in Utah.犹他州接受前列腺特异性抗原筛查男性的人口统计学和健康相关因素。
Prev Med. 2001 Dec;33(6):646-52. doi: 10.1006/pmed.2001.0940.
10
Clinical efficacy of transrectal ultrasound-guided prostate biopsy in men younger than 50 years old with an elevated prostate-specific antigen concentration (>4.0 ng/mL).经直肠超声引导下前列腺活检在前列腺特异性抗原浓度升高(>4.0ng/ml)的 50 岁以下男性中的临床疗效。
J Chin Med Assoc. 2017 Jul;80(7):413-418. doi: 10.1016/j.jcma.2016.07.007. Epub 2017 May 18.

引用本文的文献

1
Psychosocial experiences of prostate cancer survivors after treatment: a systematic review of qualitative studies.前列腺癌幸存者治疗后的心理社会经历:定性研究的系统综述
Front Public Health. 2025 Jul 24;13:1625611. doi: 10.3389/fpubh.2025.1625611. eCollection 2025.
2
The research progress on diagnostic indicators related to prostate-specific antigen gray-zone prostate cancer.与前列腺特异性抗原灰色区域前列腺癌相关的诊断指标研究进展
BMC Cancer. 2025 Aug 4;25(1):1264. doi: 10.1186/s12885-025-14505-1.
3
Knowledge and practices regarding prostate cancer screening in Spanish men: The importance of personal and clinical characteristics (PROSHADE study).西班牙语男性前列腺癌筛查知识和实践:个人和临床特征的重要性(PROSHADE 研究)。
PLoS One. 2024 May 30;19(5):e0303203. doi: 10.1371/journal.pone.0303203. eCollection 2024.

本文引用的文献

1
Factors influencing the degree of participation in surgical decision-making among Chinese patients with prostate cancer: A qualitative research.影响中国前列腺癌患者参与手术决策程度的因素:一项定性研究。
Asian J Urol. 2022 Apr;9(2):177-185. doi: 10.1016/j.ajur.2021.08.003. Epub 2021 Aug 27.
2
Early Detection of Prostate Cancer: Self-Reported Knowledge and Attitude of Physicians in Jordan.前列腺癌的早期检测:约旦医生的自我报告知识和态度。
Inquiry. 2022 Jan-Dec;59:469580221095822. doi: 10.1177/00469580221095822.
3
Investigation and analysis of public demands on health science popularization: A cross-sectional study.公众对健康科普需求的调查与分析:一项横断面研究。
Asian J Surg. 2022 Oct;45(10):1900-1901. doi: 10.1016/j.asjsur.2022.04.004. Epub 2022 Apr 15.
4
Prostate Cancer Incidence and Mortality: Global Status and Temporal Trends in 89 Countries From 2000 to 2019.前列腺癌发病率和死亡率:2000 年至 2019 年 89 个国家的全球状况和时间趋势。
Front Public Health. 2022 Feb 16;10:811044. doi: 10.3389/fpubh.2022.811044. eCollection 2022.
5
Cancer statistics in China and United States, 2022: profiles, trends, and determinants.中国和美国 2022 年癌症统计数据:概况、趋势和决定因素。
Chin Med J (Engl). 2022 Feb 9;135(5):584-590. doi: 10.1097/CM9.0000000000002108.
6
Urban-Rural Differences in Clinical Characteristics of Prostate Cancer at Initial Diagnosis: A Single-Center Observational Study in Anhui Province, China.前列腺癌初诊时临床特征的城乡差异:中国安徽省一项单中心观察性研究
Front Oncol. 2021 Aug 3;11:704645. doi: 10.3389/fonc.2021.704645. eCollection 2021.
7
Narrative review of urinary glycan biomarkers in prostate cancer.前列腺癌中尿聚糖生物标志物的叙述性综述。
Transl Androl Urol. 2021 Apr;10(4):1850-1864. doi: 10.21037/tau-20-964.
8
Screening for Prostate Cancer.前列腺癌筛查。
Med Clin North Am. 2020 Nov;104(6):1051-1062. doi: 10.1016/j.mcna.2020.08.007. Epub 2020 Sep 16.
9
The Value of Prostate-Specific Antigen-Related Indexes and Imaging Screening in the Diagnosis of Prostate Cancer.前列腺特异性抗原相关指标及影像学筛查在前列腺癌诊断中的价值
Cancer Manag Res. 2020 Aug 4;12:6821-6826. doi: 10.2147/CMAR.S257769. eCollection 2020.
10
Reconsidering Prostate Cancer Mortality - The Future of PSA Screening.重新审视前列腺癌死亡率——前列腺特异性抗原筛查的未来
N Engl J Med. 2020 Apr 16;382(16):1557-1563. doi: 10.1056/NEJMms1914228.